Innoviva (INVA) News Today $18.72 +0.07 (+0.38%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$18.00 -0.72 (-3.85%) As of 08:37 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Innoviva (NASDAQ:INVA) Upgraded at StockNews.comStockNews.com upgraded Innoviva from a "hold" rating to a "buy" rating in a research report on Wednesday.May 2 at 6:46 AM | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Acquired by Dimensional Fund Advisors LPDimensional Fund Advisors LP boosted its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 4.8% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 4,919,518 shares of the biotechnology company's stock after acquiring an additional 226,592 shMay 2 at 4:06 AM | marketbeat.comHsbc Holdings PLC Invests $5.44 Million in Innoviva, Inc. (NASDAQ:INVA)Hsbc Holdings PLC bought a new position in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 313,029 shares of the biotechnology company's stock, valued at approximaMay 1, 2025 | marketbeat.comRep. George Whitesides Unloads Shares of Innoviva, Inc. (NASDAQ:INVA)Representative George Whitesides (D-California) recently sold shares of Innoviva, Inc. (NASDAQ:INVA). In a filing disclosed on April 23rd, the Representative disclosed that they had sold between $50,001 and $100,000 in Innoviva stock on March 24th. The trade occurred in the Representative's "GEORGEApril 28, 2025 | marketbeat.comRep. George Whitesides Sells Off Shares of Innoviva, Inc. (NASDAQ:INVA)Representative George Whitesides (D-California) recently sold shares of Innoviva, Inc. (NASDAQ:INVA). In a filing disclosed on April 23rd, the Representative disclosed that they had sold between $250,001 and $500,000 in Innoviva stock on March 25th. The trade occurred in the Representative's "LORETApril 28, 2025 | marketbeat.comMarshall Wace LLP Buys 178,583 Shares of Innoviva, Inc. (NASDAQ:INVA)Marshall Wace LLP raised its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 130.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 314,968 shares of the biotechnology company's stockApril 26, 2025 | marketbeat.comStockNews.com Downgrades Innoviva (NASDAQ:INVA) to HoldStockNews.com lowered shares of Innoviva from a "buy" rating to a "hold" rating in a report on Tuesday.April 23, 2025 | marketbeat.comInvesco Ltd. Has $18.25 Million Stock Holdings in Innoviva, Inc. (NASDAQ:INVA)Invesco Ltd. decreased its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 27.5% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,051,879 shares of the biotechnology company's stock afterApril 21, 2025 | marketbeat.comLSV Asset Management Has $696,000 Position in Innoviva, Inc. (NASDAQ:INVA)LSV Asset Management decreased its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 59.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,094 shares of the biotechnology company's stock after sellingApril 17, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Raised to Buy at StockNews.comStockNews.com upgraded Innoviva from a "hold" rating to a "buy" rating in a research report on Monday.April 16, 2025 | marketbeat.comRussell Investments Group Ltd. Decreases Stock Position in Innoviva, Inc. (NASDAQ:INVA)Russell Investments Group Ltd. cut its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 79.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 373,266 shares of the biotechnology company's stock afApril 15, 2025 | marketbeat.comNorges Bank Takes $1.48 Million Position in Innoviva, Inc. (NASDAQ:INVA)Norges Bank purchased a new position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 85,282 shares of the biotechnology company's stock, valued at approximately $1,480,0April 14, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by Renaissance Technologies LLCRenaissance Technologies LLC lowered its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 1.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,261,732 shares of the bioApril 12, 2025 | marketbeat.comVanguard Group Inc. Buys 84,934 Shares of Innoviva, Inc. (NASDAQ:INVA)Vanguard Group Inc. boosted its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 1.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 6,312,631 shares of the biotechnology company's stock after purchasinApril 10, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Shares Sold by ExodusPoint Capital Management LPExodusPoint Capital Management LP decreased its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 59.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 138,689 shares of the bioteApril 9, 2025 | marketbeat.comDynamic Technology Lab Private Ltd Makes New Investment in Innoviva, Inc. (NASDAQ:INVA)Dynamic Technology Lab Private Ltd purchased a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 43,225 shares of the biotechnology company's stoApril 8, 2025 | marketbeat.comArrowstreet Capital Limited Partnership Grows Holdings in Innoviva, Inc. (NASDAQ:INVA)Arrowstreet Capital Limited Partnership increased its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 7.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,146,243 shares of the biotechnApril 5, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Downgraded to Hold Rating by StockNews.comStockNews.com cut Innoviva from a "buy" rating to a "hold" rating in a research note on Tuesday.April 3, 2025 | marketbeat.comPrudential Financial Inc. Acquires 110,246 Shares of Innoviva, Inc. (NASDAQ:INVA)Prudential Financial Inc. boosted its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 157.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 180,122 shares of the biotechnology companApril 3, 2025 | marketbeat.com72,400 Shares in Innoviva, Inc. (NASDAQ:INVA) Acquired by KLP Kapitalforvaltning ASKLP Kapitalforvaltning AS acquired a new stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 72,400 shares of the biotechnology company's stock, valued at approximately $1,256,000March 31, 2025 | marketbeat.comAmerican Century Companies Inc. Purchases 370,795 Shares of Innoviva, Inc. (NASDAQ:INVA)American Century Companies Inc. increased its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 35.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,424,315 shares of the biotechnology company'sMarch 31, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Trading Up 2.2% - Here's WhyInnoviva (NASDAQ:INVA) Stock Price Up 2.2% - Here's What HappenedMarch 29, 2025 | marketbeat.comFox Run Management L.L.C. Takes $378,000 Position in Innoviva, Inc. (NASDAQ:INVA)Fox Run Management L.L.C. acquired a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 21,804 shares of the biotechnology company's stock, valued at approximately $378,000. Several other inMarch 27, 2025 | marketbeat.comIntech Investment Management LLC Has $609,000 Holdings in Innoviva, Inc. (NASDAQ:INVA)Intech Investment Management LLC raised its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 79.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 35,128 shares of the biotecMarch 25, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Sells 104,634 Shares of Innoviva, Inc. (NASDAQ:INVA)Charles Schwab Investment Management Inc. lessened its holdings in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 14.3% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 627,662 shares of the biotechnology company's stock after selling 104,634 shares dMarch 23, 2025 | marketbeat.comBoston Partners Purchases 149,060 Shares of Innoviva, Inc. (NASDAQ:INVA)Boston Partners lifted its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 43.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 490,404 shares of the biotechnology company's stockMarch 22, 2025 | marketbeat.comBillionaire Healthcare Investor Alex Denner’s Hedge Fund Has 75% of Its Assets in These 3 StocksMarch 17, 2025 | msn.comBillionaire Healthcare Investor Alex Denner's Hedge Fund Has 75% of Its Assets in These 3 StocksMarch 17, 2025 | 247wallst.comInnoviva, Inc. (NASDAQ:INVA) Shares Purchased by Victory Capital Management Inc.Victory Capital Management Inc. increased its position in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 26.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 177,383 shares of theMarch 17, 2025 | marketbeat.comWEX, Lamb Weston, and More Stocks See Action From Activist InvestorsMarch 15, 2025 | msn.comInnoviva (NASDAQ:INVA) Downgraded by StockNews.com to HoldStockNews.com lowered shares of Innoviva from a "buy" rating to a "hold" rating in a research report on Saturday.March 15, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Sees Strong Trading Volume - What's Next?Innoviva (NASDAQ:INVA) Sees Strong Trading Volume - Here's WhyMarch 14, 2025 | marketbeat.comArmata Pharmaceuticals Announces $10 Million Secured Credit Agreement with InnovivaMarch 12, 2025 | prnewswire.comAlphaQuest LLC Buys New Shares in Innoviva, Inc. (NASDAQ:INVA)AlphaQuest LLC bought a new stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 48,878 shares of the biotechnology company's stock, valued at approxiMarch 11, 2025 | marketbeat.comInceptionr LLC Acquires Shares of 16,542 Innoviva, Inc. (NASDAQ:INVA)Inceptionr LLC bought a new position in Innoviva, Inc. (NASDAQ:INVA - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 16,542 shares of the biotechnology company's stock, valued atMarch 10, 2025 | marketbeat.comInnoviva (NASDAQ:INVA) Raised to "Buy" at StockNews.comStockNews.com upgraded Innoviva from a "hold" rating to a "buy" rating in a report on Friday.March 8, 2025 | marketbeat.comScotiabank Initiates Coverage of Innoviva (INVA) with Sector Outperform RecommendationMarch 8, 2025 | msn.comInnoviva (NASDAQ:INVA) Coverage Initiated by Analysts at ScotiabankScotiabank began coverage on Innoviva in a research note on Friday. They set a "sector outperform" rating and a $55.00 price target on the stock.March 8, 2025 | marketbeat.comInnoviva, Inc. (NASDAQ:INVA) Major Shareholder Sells $2,665,215.25 in StockInnoviva, Inc. (NASDAQ:INVA - Get Free Report) major shareholder Alexander J. Denner sold 151,175 shares of the business's stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $17.63, for a total transaction of $2,665,215.25. Following the sale, the insider now directly owns 7,125,825 shares in the company, valued at $125,628,294.75. The trade was a 2.08 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Large shareholders that own more than 10% of a company's stock are required to disclose their transactions with the SEC.March 8, 2025 | marketbeat.comAlexander J. Denner Sells 1,196,746 Shares of Innoviva, Inc. (NASDAQ:INVA) StockInnoviva, Inc. (NASDAQ:INVA - Get Free Report) major shareholder Alexander J. Denner sold 1,196,746 shares of the stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $17.52, for a total value of $20,966,989.92. Following the sale, the insider now directly owns 5,658,705 shares of the company's stock, valued at approximately $99,140,511.60. This represents a 17.46 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Major shareholders that own more than 10% of a company's stock are required to disclose their sales and purchases with the SEC.March 8, 2025 | marketbeat.comInnoviva initiated with an Outperform at ScotiabankMarch 7, 2025 | markets.businessinsider.comInnoviva to Participate in the Barclays 27th Annual Global Healthcare ConferenceMarch 6, 2025 | finance.yahoo.comInnoviva (NASDAQ:INVA) Posts Quarterly Earnings ResultsInnoviva (NASDAQ:INVA - Get Free Report) announced its quarterly earnings results on Wednesday. The biotechnology company reported $0.57 earnings per share (EPS) for the quarter. Innoviva had a return on equity of 20.84% and a net margin of 18.31%.February 27, 2025 | marketbeat.comInnoviva (INVA) to Release Earnings on ThursdayInnoviva (NASDAQ:INVA) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.comTheravance Biopharma Inc (TBPH) Q4 2024 Earnings Call Highlights: Record Sales and Strategic ...February 27, 2025 | gurufocus.comQ4 2024 Theravance Biopharma Inc Earnings Call TranscriptFebruary 27, 2025 | gurufocus.comTheravance Biopharma: Balancing Growth Potential and Uncertainty with a Hold RatingFebruary 26, 2025 | tipranks.comInnoviva Reports Fourth Quarter and Full Year 2024 Financial Results; Highlights Recent Company ProgressFebruary 26, 2025 | businesswire.comDenali Advisors LLC Lowers Holdings in Innoviva, Inc. (NASDAQ:INVA)Denali Advisors LLC lowered its stake in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 6.9% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 354,324 shares of the biotechnology company's stock after selling 26,078 shares during the period. DenaliFebruary 26, 2025 | marketbeat.comInnoviva: Underappreciated Strength In Hospital TherapeuticsFebruary 23, 2025 | seekingalpha.com Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address INVA Media Mentions By Week INVA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INVA News Sentiment▼1.270.73▲Average Medical News Sentiment INVA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INVA Articles This Week▼32▲INVA Articles Average Week Get Innoviva News Delivered to You Automatically Sign up to receive the latest news and ratings for INVA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alkermes News Amicus Therapeutics News Ligand Pharmaceuticals News BioCryst Pharmaceuticals News MannKind News Celldex Therapeutics News Dynavax Technologies News Novavax News OPKO Health News Geron News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:INVA) was last updated on 5/5/2025 by MarketBeat.com Staff From Our PartnersElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredShocking AI play that’s beats Nvidia by a country mileYou’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMan who predicted $100K Bitcoin sees a huge run coming for another coin …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredMusk's warning signal: Prepare before the cascade beginsWhen Elon Musk triggered his AI layoff plan, most analysts missed what it really meant. Louis Navellier didn’t...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innoviva, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innoviva With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INVA with Qtrade Free INVA Stock Alerts